---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-074243"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:09:13.690658+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Design Therapeutics stockholders elect Pratik Shah as Class III director, ratify EY auditor

## Summary
- Pratik Shah, Ph.D. elected as Class III director with ~42.8M votes for, ~3.5M withheld (7.7M broker non-votes).
- Ernst & Young LLP ratified as independent auditor for FY2024 (53,981,806 for, 2,764 against, 2 abstentions).
- Annual Meeting held June 13, 2024; 56,495,039 shares outstanding and entitled to vote as of record date.

## SEC filing metadata
- accession: 0000950170-24-074243
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000095017024074243/0000950170-24-074243-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000095017024074243/dsgn-20240613.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-074243
- JSON: https://secwatch.observer/filing/0000950170-24-074243.json
- Plain text: https://secwatch.observer/filing/0000950170-24-074243.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.